Effects of Personalized Training at Home Combining Endurance and Resistance in Patients Suffering From Marfan Syndrome
-
- STATUS
- Recruiting
-
- End date
- Sep 30, 2022
-
- participants needed
- 90
-
- sponsor
- French Cardiology Society
Summary
Marfan syndrome (MS) is an autosomal dominant genetic disorder caused by a mutation in the fibrillin-1 gene (FBN1) encoding the protein fibrillin-1. Fibrillin is the main component of microfibrils, elements found in all of the body's tissues, and this pathology is characterized by the multitude of its clinical manifestations. These patients may develop aneurysms in the aortic root and one of the main factors of morbidity in patients with MS is aortic dissection. Prevention mainly involves preventive aortic surgery. However, the repercussions are global and can affect the functioning of other tissues such as skeletal muscle tissue, bone tissue, lung tissue and the eyes. The association of skeletal (scoliosis, hyperlaxity), muscular and ocular disorders is clearly associated with an impairment in the quality of life. These disorders are associated with pain and disability which affect professional activity, leisure and family life.
Physical activity could represent a relevant alternative for these patients. A recent animal study suggests that moderate training is beneficial.
Description
The main objective is to show that the quality of life of patients with Marfan syndrome can be improved by personalized training at home. The goal is to be able to offer new non-drug management based on physical activity to these patients.
Improved quality of life; Improvement of muscle strength by a muscle strengthening protocol; Improvement of cardiovascular function parameters. Regular coaching throughout the study.
- / Assessment of muscular capacities
- / Assessment of cardiovascular and respiratory capacities
- / Response to psychometric questionnaires
- / Participation in a training circuit (training protocol)
Details
| Condition | CONNECTIVE TISSUE DISEASE, Connective Tissue Diseases, Dermatomyositis (Connective Tissue Disease), Congenital Heart Defect, Congenital Heart Disease, Heart Defect, Marfan's Syndrome, Congenital Heart Disease, Dermatomyositis (Connective Tissue Disease), Connective Tissue Diseases, Heart Defect, marfan syndrome, marfans syndrome |
|---|---|
| Treatment | Endurance training, Muscle building training |
| Clinical Study Identifier | NCT04553094 |
| Sponsor | French Cardiology Society |
| Last Modified on | 18 April 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer